Research Focus

Medicine; Assistant Attending L1

Recent additions – View all

1. Mutant RUNX1, SETBP1 and IDH mutant allele dynamics as biomarkers of hematologic response to IDH inhibitors in myeloid malignancies

   Meeting Abstract

   Chernak, B.; Song, A.; May, B.; Viny, A. D.
   Blood (2024)

   Fulltext@MSK | Save
2. Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies

   Review

   Chernak, B. J.; Rampal, R. K.
   International Review of Cell and Molecular Biology (2021)

   Fulltext@MSK | Save
3. Atypical presentation of erythroid/megakaryocytic leukemic transformation of a myeloproliferative neoplasm associated with mutation and loss of TP53

   Journal Article

   Chernak, B. J.; Sen, F.; Farnoud, N.; Bou Ayache, J.; Zhang, Y.; DeWolf, S.; Rampal, R. K.
   HemaSphere (2020)

   Fulltext@MSK | Save